Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed (HIPEC)
Register With Data From Patients With the Diagnosis of a Peritoneal Surface Malignancy, for Which Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) is Performed
Sponsor: Universitaire Ziekenhuizen KU Leuven
A observational or N/A phase clinical study on Peritoneal Carcinomatosis and Peritoneal Mesothelioma, this trial is actively recruiting participants. The trial is conducted by Universitaire Ziekenhuizen KU Leuven and has accumulated 10 data snapshots since 2012. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Apr 2023 — Jul 2024 [monthly]
Recruiting
-
Nov 2022 — Apr 2023 [monthly]
Recruiting
-
Nov 2021 — Nov 2022 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Recruiting
-
Nov 2018 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
May 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .